ARS Pharmaceuticals, Inc.
USD8.52
-0.04 (-0.47%)
CEO
Richard E. Lowenthal
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.45
Prev. Close
$8.56
Day Low
$8.45
Day High
$8.64
52W Low
$6.66
52W High
$18.63
Market Cap
$0.85B
Volume
0.06M
| 30,000 |
| $10.54 |
| 26 Jun 2026 | Shah Pratik | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | Kelly Michael | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | Islam Saqib | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | Thompson Peter A. | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | SAUNDERS BRENT L | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | SCHNEIDER PHILLIP M | director | A-Award | Acquired | 30,000 | $10.54 |
| 26 Jun 2026 | Shawver Laura | director | A-Award | Acquired | 30,000 | $10.54 |
| 12 Jun 2026 | Karas Eric | Chief Commercial Officer | M-Exempt | Acquired | 25,000 | $1.50 |